HABP2

hyaluronan binding protein 2

Basic information

Region (hg38): 10:113550837-113589602

Links

ENSG00000148702NCBI:3026OMIM:603924HGNC:4798Uniprot:Q14520AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Thyroid cancer, nonmedullary 5ADOncologicIndividuals have been described as being susceptible to nonmedullary thyroid cancer, and awareness may allow early surveillance, diagnosis, and managementOncologic26222560

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the HABP2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the HABP2 gene is commonly pathogenic or not. These statistics are base on transcript: . Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
11
clinvar
3
clinvar
3
clinvar
17
missense
86
clinvar
10
clinvar
96
nonsense
0
start loss
0
frameshift
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total 0 0 98 14 3
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
HABP2protein_codingprotein_codingENST00000351270 1338766
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.96e-150.054712505036951257480.00278
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.433853141.230.00001603726
Missense in Polyphen127106.931.18761298
Synonymous-1.341401211.160.00000683997
Loss of Function0.6902529.00.8620.00000123362

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.004510.00451
Ashkenazi Jewish0.006160.00617
East Asian0.0003820.000381
Finnish0.00004620.0000462
European (Non-Finnish)0.003830.00382
Middle Eastern0.0003820.000381
South Asian0.0004590.000457
Other0.005550.00555

dbNSFP

Source: dbNSFP

Function
FUNCTION: Cleaves the alpha-chain at multiple sites and the beta- chain between 'Lys-53' and 'Lys-54' but not the gamma-chain of fibrinogen and therefore does not initiate the formation of the fibrin clot and does not cause the fibrinolysis directly. It does not cleave (activate) prothrombin and plasminogen but converts the inactive single chain urinary plasminogen activator (pro- urokinase) to the active two chain form. Activates coagulation factor VII (PubMed:8827452, PubMed:10754382, PubMed:11217080). May function as a tumor suppressor negatively regulating cell proliferation and cell migration (PubMed:26222560). {ECO:0000269|PubMed:10754382, ECO:0000269|PubMed:11217080, ECO:0000269|PubMed:26222560, ECO:0000269|PubMed:8827452}.;
Disease
DISEASE: Thyroid cancer, non-medullary, 5 (NMTC5) [MIM:616535]: A form of non-medullary thyroid cancer (NMTC), a cancer characterized by tumors originating from the thyroid follicular cells. NMTCs represent approximately 95% of all cases of thyroid cancer and are classified into papillary, follicular, Hurthle cell, and anaplastic neoplasms. {ECO:0000269|PubMed:12578864, ECO:0000269|PubMed:26222560}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.109

Intolerance Scores

loftool
0.123
rvis_EVS
-0.06
rvis_percentile_EVS
48.89

Haploinsufficiency Scores

pHI
0.454
hipred
N
hipred_score
0.180
ghis
0.399

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0875

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Habp2
Phenotype
homeostasis/metabolism phenotype; immune system phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
proteolysis;cell adhesion
Cellular component
extracellular region;extracellular space
Molecular function
serine-type endopeptidase activity;calcium ion binding;glycosaminoglycan binding